Keith Woods - 16 Oct 2023 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Director
Signature
/s/ Adam S. Mostafa, attorney-in-fact
Issuer symbol
XFOR
Transactions as of
16 Oct 2023
Net transactions value
$0
Form type
4
Filing time
18 Oct 2023, 16:02:34 UTC
Next filing
08 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Award $0 +90,000 $0.000000 90,000 16 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock units ("RSUs") grant. The RSUs will vest in three equal annual installments commencing on October 16, 2024, subject to the Reporting Person's continued service as a director through each such date.